Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)

---
identifier: "/us/fr/2012-13922"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)"
title_number: 0
title_name: "Federal Register"
section_number: "2012-13922"
section_name: "Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES)"
positive_law: false
currency: "2012-06-08"
last_updated: "2012-06-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-13922"
document_type: "notice"
publication_date: "2012-06-08"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "77 FR 34046"
fr_volume: 77
---


#  Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Ethics Subcommittee (ES)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the CDC announces the following meeting of the aforementioned subcommittee:

*Time and Date:* 9:30 a.m.-12:30 p.m. EDT, Friday, June 29, 2012.

*Place:* Teleconference.

*Status:* Open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment period. A public comment period is tentatively scheduled for 12 p.m.-12:15 p.m. To participate in the teleconference, please dial (877) 928-1204 and enter code 4305992.

*Purpose:* The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners.

*Matters To Be Discussed:* Agenda items will include the following: Addition of ethics standards to the accreditation process for public health departments; ethical considerations relating to use of travel restrictions for the control of communicable diseases and possible revisions to CDC's standard operating procedures; progress on developing practical tools to assist state, tribal, local, and territorial health departments in their efforts to address public health ethics challenges; approaches for evaluating the impact of public health ethics; and strategies for increasing collaboration between public health ethics and public health law.

The agenda is subject to change as priorities dictate.

*Contact Person for More Information:* Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC-ES, 1600 Clifton Road NE., M/S D-50, Atlanta, Georgia 30333. Telephone: (404) 639-4690. Email: *[email protected].*

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: June 4, 2012.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.